Prevalence of latent tuberculosis infection in healthcare workers in poland assessed by interferon-gamma whole blood and tuberculin skin tests

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL. 6, 2008, Pages 209-217

  Demkow, U ^a,b   Broniarek Samson, B ^a   Filewska, M ^a   Lewandowska, K ^a   Maciejewski, J ^c   Zycinska, K ^b   Zwolska, Z ^a   Kus, J ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Family Medicine Practice   (Poland)

Author keywords

Health care workers; Interferon gamma; Quantiferon TB Gold; Tuberculin skin test; Tuberculosis

Indexed keywords

GAMMA INTERFERON;

ADULT; AGE; AGED; ARTICLE; BCG VACCINATION; BLOOD ANALYSIS; EMPLOYMENT; FEMALE; HEALTH CARE PERSONNEL; HUMAN; IMMUNE RESPONSE; INFECTION RISK; LABORATORY PERSONNEL; MALE; NURSE; OCCUPATIONAL EXPOSURE; POLAND; PREVALENCE; SCAR FORMATION; SOCIOECONOMICS; TUBERCULIN TEST; TUBERCULOSIS; WORK ENVIRONMENT; BLOOD; LUNG TUBERCULOSIS; MEDICAL PROFESSION; MIDDLE AGED; RISK FACTOR; STATISTICS;

ADULT; AGE FACTORS; AGED; FEMALE; HEALTH OCCUPATIONS; HEALTH PERSONNEL; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; POLAND; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 64549091464     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gruzlica i Choroby Ukladu Oddechowego w Polsce w 2004. I Szczuka (ed). Warszawa, Instytut Grozlicy i Choroby Pluc, 2005.
2. Zwolska Z, Augustynowicz-Kopec E, Domagala-Krzewniak A et al. Ryzyko narazenia na gruzlice jako chorobe zawodowa u personelu medycznego. Zakazenia 2001; 2: 17-22 (in Polish).
3. Demkow U, Filewska M, Michalowska-Mitczuk D et al. Heterogeneity of antibody response to myobacterial antigens in different clinical manifestations of pulmonary tuberculosis. J Physiol Pharmacol 2007; 58 Suppl 5: 117-127.
4. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect Dis 2006; 6: 710-725.
5. Al Zaharani K, Al Jahdali H, Menzies D. Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease. Am J Respir Crit Care Med 2000; 162: 1419-1422
6. Dheda K, Chang JS, Kim LU, Huggett JF, Johnson MA et al. Interferon gamma assays for tuberculosis. Lancet Infect Dis 2005; 5: 324-325.
7. Lalvani A, Richeldi L, Kunst H. Interferon gamma assays for tuberculosis. Lancet Infect Dis 2005; 5: 322-324.
8. Pai M, Dheda K, Cunningham J et al. T-Cell Assays for the diagnosis of latent tuberculosis infection: Moving the research agenda forward. Lancet Infect Dis 2007; 7: 428-438.
9. Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med 2006; 3: e494.
10. Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007; 11: 593-605.
11. American Thoracic Society and the Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221-S247.
12. Pai M, Joshi R, Dogra S et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006; 174: 349-355.
13. Pai M, Gokhale K, Joshi R et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005; 293: 2746-2755.
14. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161: 1376-1395.
15. Mori T, Sakatani M, Yamagishi F et al. Specific detection of tuberculosis infection: An interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59-64.
16. Drobniewski FA, Tayler E, Ignatenko N et al. TB in Siberia 2- diagnosis, chemoprophylaxis and treatment. Tuber Lung Disease 1996; 77: 297-301.
17. Mirtskhulava V, Kempker R, Shields KL et al. Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia. Int J Tuberc Lung Dis 2008; 12: 513-519.
18. Drobniewski F, Balabanova Y, Zakamova E et al. Rates of latent tuberculosis in health care staff in Russia. Plos Med 2007; 4: e55.
19. Harries AD, Maher D, Nunn P. Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries. Bull World Health Organ 1997; 75: 477-489.
20. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings. MMWR Recomm Rep 2005; 54: 1-141.
21. Fella P, Rivera P, Hale M et al. Dramatic decrease in tuberculin skin test conversion rate among employees at a hospital in New York City. Am J Infect Control 1995; 23: 352-356.
22. Seidler A, Nienhaus A, Diel R. Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas. Respiration 2005; 2: 431-446.
23. Raviglione M. XDR-TB. Entering the post-antibiotic era? Int J Tuberc Lung Dis 2006; 10: 1185-1187.
24. Granich, R, Binkin, NJ, Jarvis WR et al. Guidelines for the prevention of tuberculosis in health care facilities in resource-limited settings. WHO/CDS/TB/99.269.Geneva, Switzerland: World Health Organization; 1999; 51.
25. Mazurek GH, Jereb J, Lobue P et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54: 49-55.